Debate Over Autism Treatments and FDA Approvals
TL;DR Summary
The Trump administration approved leucovorin, a vitamin B derivative, as a treatment for autism based on limited evidence, surprising experts and the drug's original proposer, Dr. Richard Frye, amid ongoing debates about its efficacy and the need for further research.
- Trump's touting of an unproven autism drug surprised many, including the doctor who proposed it AP News
- Is leucovorin an effective treatment for autism? Here's what research shows NBC News
- F.D.A.’s Approval of a Drug for Autism Upends Review Process The New York Times
- GSK to submit label update for Wellcovorin (leucovorin) at US FDA’s request GSK
- 'It's a different way of being.' A cure for autism isn't what these families say they need USA Today
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
5 min
vs 6 min read
Condensed
96%
1,093 → 40 words
Want the full story? Read the original article
Read on AP News